Chemed Past Earnings Performance
Past criteria checks 6/6
Chemed has been growing earnings at an average annual rate of 2.4%, while the Healthcare industry saw earnings growing at 6.2% annually. Revenues have been growing at an average rate of 3.7% per year. Chemed's return on equity is 24.9%, and it has net margins of 12.9%.
Key information
2.4%
Earnings growth rate
4.1%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | 3.7% |
Return on equity | 24.9% |
Net Margin | 12.9% |
Next Earnings Update | 29 Oct 2024 |
Recent past performance updates
Recent updates
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future
Aug 26Chemed Remains A Buy On Long-Term Economics
Aug 16Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon
Jul 19Chemed: Growth Does Not Justify The Current Stock Price
May 20Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns
May 14Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?
Apr 26Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year
Mar 01The Price Is Right For Chemed Corporation (NYSE:CHE)
Dec 30Chemed: Continues To Compound Shareholder Value At Double-Digit Returns
Nov 30Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns
Oct 26Chemed - Showcasing Why It's So Reliable
Aug 26Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked
Aug 13Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?
Aug 01Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future
Jul 14Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet
Jun 07Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns
Apr 09Chemed Q4 2022 Earnings Preview
Feb 22Chemed Corporation: Long-Term Tailwinds, But Remains A Hold
Feb 14Is Chemed (NYSE:CHE) Using Too Much Debt?
Jan 05Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean
Dec 17Chemed declares $0.38 dividend
Nov 04Chemed Q3 2022 Earnings Preview
Oct 28Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?
Oct 01Capital Investment Trends At Chemed (NYSE:CHE) Look Strong
Sep 16Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns
Aug 26A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)
Aug 16Revenue & Expenses Breakdown
How Chemed makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 2,336 | 301 | 413 | 0 |
31 Mar 24 | 2,293 | 283 | 411 | 0 |
31 Dec 23 | 2,264 | 273 | 395 | 0 |
30 Sep 23 | 2,225 | 245 | 392 | 0 |
30 Jun 23 | 2,187 | 226 | 376 | 0 |
31 Mar 23 | 2,165 | 240 | 369 | 0 |
31 Dec 22 | 2,135 | 250 | 359 | 0 |
30 Sep 22 | 2,129 | 262 | 354 | 0 |
30 Jun 22 | 2,141 | 277 | 359 | 0 |
31 Mar 22 | 2,142 | 267 | 365 | 0 |
31 Dec 21 | 2,139 | 269 | 367 | 0 |
30 Sep 21 | 2,132 | 308 | 361 | 0 |
30 Jun 21 | 2,121 | 303 | 361 | 0 |
31 Mar 21 | 2,091 | 329 | 351 | 0 |
31 Dec 20 | 2,080 | 319 | 330 | 0 |
30 Sep 20 | 2,069 | 271 | 322 | 0 |
30 Jun 20 | 2,021 | 263 | 311 | 0 |
31 Mar 20 | 1,992 | 231 | 298 | 0 |
31 Dec 19 | 1,939 | 220 | 306 | 0 |
30 Sep 19 | 1,874 | 209 | 289 | 0 |
30 Jun 19 | 1,837 | 201 | 279 | 0 |
31 Mar 19 | 1,806 | 205 | 276 | 0 |
31 Dec 18 | 1,783 | 206 | 271 | 0 |
30 Sep 18 | 1,753 | 206 | 276 | 0 |
30 Jun 18 | 1,727 | 190 | 275 | 0 |
31 Mar 18 | 1,700 | 113 | 271 | 0 |
31 Dec 17 | 1,667 | 98 | 271 | 0 |
30 Sep 17 | 1,642 | 76 | 261 | 0 |
30 Jun 17 | 1,617 | 67 | 254 | 0 |
31 Mar 17 | 1,592 | 114 | 249 | 0 |
31 Dec 16 | 1,577 | 109 | 238 | 0 |
30 Sep 16 | 1,572 | 106 | 240 | 0 |
30 Jun 16 | 1,566 | 108 | 234 | 0 |
31 Mar 16 | 1,557 | 111 | 233 | 0 |
31 Dec 15 | 1,543 | 110 | 233 | 0 |
30 Sep 15 | 1,524 | 110 | 229 | 0 |
30 Jun 15 | 1,496 | 106 | 229 | 0 |
31 Mar 15 | 1,475 | 103 | 224 | 0 |
31 Dec 14 | 1,456 | 99 | 220 | 0 |
30 Sep 14 | 1,425 | 92 | 216 | 0 |
30 Jun 14 | 1,408 | 85 | 211 | 0 |
31 Mar 14 | 1,405 | 76 | 210 | 0 |
31 Dec 13 | 1,413 | 77 | 213 | 0 |
30 Sep 13 | 1,433 | 81 | 209 | 0 |
Quality Earnings: CHE has high quality earnings.
Growing Profit Margin: CHE's current net profit margins (12.9%) are higher than last year (10.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CHE's earnings have grown by 2.4% per year over the past 5 years.
Accelerating Growth: CHE's earnings growth over the past year (32.9%) exceeds its 5-year average (2.4% per year).
Earnings vs Industry: CHE earnings growth over the past year (32.9%) exceeded the Healthcare industry 8%.
Return on Equity
High ROE: CHE's Return on Equity (24.9%) is considered high.